Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL

NCT01897571 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Lymphomas (Phase 1)
Advanced Solid Tumors (Phase 1)
Diffuse Large B-cell Lymphoma (Phase 2)
Follicular Lymphoma (Phase 2)
Transformed Follicular Lymphoma
Primary Mediastinal Large B-Cell Lymphoma

Interventions

DRUG: Tazemetostat
DRUG: Prednisolone
DRUG: Tazemetostat

Sponsor

Epizyme, Inc.